The Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response yesterday announced a $9.3 million contract to develop a test that could help hospital and commercial laboratories speed diagnosis of bacterial infections and determine the best antibiotics to treat them. ASPR’s Biomedical Advanced Research and Development Authority will sponsor advanced development of the testing technology under an 18-month contract with SeLux Diagnostic Inc. The agency said the technology aims to reduce the time needed to diagnose bacterial infections from days to hours and curb antibiotic-resistant infections.

Related News Articles

Headline
The Administration for Strategic Preparedness and Response June 25 announced it conducted an exercise transporting simulated patients with high-consequence…
Headline
Ochsner Health's Stephen Saenz, sepsis program manager, and Teresa Arrington, director of robust process improvement for quality and patient safety, reveal how…
Headline
The Centers for Disease Control and Prevention has added new resources for health care providers to its Be Ready for Measles Toolkit. They include a decision…
Headline
There have been 1,168 confirmed cases of measles across 33 states as of June 6 this year, according to the latest data from the Centers for Disease Control and…
Headline
A JAMA study published June 3 found that of 2,237 counties across the U.S., 78% reported declines in vaccination rates for measles, mumps and rubella from 2019…
Headline
There have been 1,024 confirmed cases of measles across the U.S. so far in 2025, according to the latest data from the Centers for Disease Control and…